Published in Front Neurol on March 08, 2017
Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science (1994) 18.08
Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science (2010) 12.15
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat Neurosci (2007) 7.42
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nat Neurosci (2007) 6.23
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat Neurosci (2011) 4.21
Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia (1998) 2.82
The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J Neurosci Methods (2002) 2.81
Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med (2014) 2.68
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest (2012) 2.67
Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis (2005) 2.16
Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell (2009) 2.10
Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J Neurosci (2003) 1.96
A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep (2013) 1.92
Origin of monocytes and macrophages in a committed progenitor. Nat Immunol (2013) 1.84
Hematopoietic origin of microglial and perivascular cells in brain. Exp Neurol (2004) 1.75
Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies. J Am Assoc Lab Anim Sci (2009) 1.39
Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair. Front Cell Neurosci (2013) 1.34
Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis. Glia (2006) 1.30
Decoding ALS: from genes to mechanism. Nature (2016) 1.18
Bone marrow cell recruitment to the brain in the absence of irradiation or parabiosis bias. PLoS One (2013) 1.12
Brain conditioning is instrumental for successful microglia reconstitution following hematopoietic stem cell transplantation. Proc Natl Acad Sci U S A (2012) 1.12
Origin, fate and dynamics of macrophages at central nervous system interfaces. Nat Immunol (2016) 1.03
Migration of bone marrow-derived cells into the central nervous system in models of neurodegeneration. J Comp Neurol (2013) 1.01
Toxicological review of busulfan (Myleran). Mutat Res (1986) 0.98
Busulfan conditioning enhances engraftment of hematopoietic donor-derived cells in the brain compared with irradiation. Mol Ther (2013) 0.97
In and out of the niche: perspectives in mobilization of hematopoietic stem cells. Exp Hematol (2011) 0.95
Pilot study of granulocyte colony stimulating factor (G-CSF)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (ALS). Muscle Nerve (2008) 0.93
Aspects concerning busulfan pharmacokinetics and bioavailability. Leuk Lymphoma (1996) 0.86
Safety and feasibility of long term administration of recombinant human granulocyte-colony stimulating factor in patients with amyotrophic lateral sclerosis. Cytokine (2014) 0.84
Stem cell factor and granulocyte colony-stimulating factor reduce β-amyloid deposits in the brains of APP/PS1 transgenic mice. Alzheimers Res Ther (2011) 0.84
Personalized busulfan and treosulfan conditioning for pediatric stem cell transplantation: the role of pharmacogenetics and pharmacokinetics. Drug Discov Today (2014) 0.84
Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF. Hum Immunol (2007) 0.83
Nonmyeloablative conditioning generates autoantigen-encoding bone marrow that prevents and cures an experimental autoimmune disease. Am J Transplant (2012) 0.83
Towards a myeloablative regimen with clinical potential: I. Treosulfan conditioning and bone marrow transplantation allow induction of donor-specific tolerance for skin grafts across full MHC barriers. Bone Marrow Transplant (2003) 0.83
Myelosuppressive conditioning using busulfan enables bone marrow cell accumulation in the spinal cord of a mouse model of amyotrophic lateral sclerosis. PLoS One (2013) 0.82
Submyeloablative conditioning with busulfan permits bone marrow-derived cell accumulation in a murine model of Alzheimer's disease. Neurosci Lett (2015) 0.78
Busulfan as a myelosuppressive agent for generating stable high-level bone marrow chimerism in mice. J Vis Exp (2015) 0.77
Penetration of Treosulfan and its Active Monoepoxide Transformation Product into Central Nervous System of Juvenile and Young Adult Rats. Drug Metab Dispos (2015) 0.77
Myeloid cell-based therapies in neurological disorders: How far have we come? Biochim Biophys Acta (2015) 0.77
Transport of treosulfan and temozolomide across an in-vitro blood-brain barrier model. Anticancer Drugs (2015) 0.76